2 completed, 2 terminated, 1 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 2, Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow ARC 1779: new trials by email Literature Review of ARC 1779 trials Research Report on ARC 1779
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy ARC1779 Injection, Placebo (normal saline) - Intracranial Embolism, Cerebral Thromboembolism | Phase 2 | Terminated | Archemix Corp. | 100 | 2009-02-01 | 2010-02-10 |
| Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy ARC 1779 Placebo, ARC1779 Injection - Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura | Phase 2 | Terminated | Archemix Corp. | 100 | 2008-12-01 | 2009-11-26 |
| A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B ARC1779 - Von Willebrand Disease | Phase 2 | Withdrawn | Archemix Corp. | 2 | 2008-10-01 | 2009-08-21 |
| ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders ARC1779 - Purpura, Thrombotic Thrombocytopenic, Von Willebrand Disease Type-2b | Phase 2 | Completed | Archemix Corp. | 28 | 2008-01-01 | 2009-01-09 |
| Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers ARC1779 - Thrombosis | Phase 1 | Completed | Archemix Corp. | 42 | 2006-12-01 | 2007-04-20 |
Purpura, Thrombotic Thrombocytopenic (2) · Anemia, Hemolytic (1) · Carotid Stenosis (1) · Intracranial Embolism (1) · Thrombocytopenia (1) · Thrombosis (1) · Thrombotic Microangiopathies (1) · von Willebrand Diseases (1)
Archemix Corp. (5)
United States (3) · Austria (2) · United Kingdom (2) · Canada (1) · Italy (1)
Hugh Markus, MD (1)